Obesity and Diabetes induced cardiomyopathy

肥胖和糖尿病引起的心肌病

• 批准号: 6485152
• 负责人: TAL M LEWIN
• 金额: $ 8.98万
• 依托单位: UNIV OF NORTH CAROLINA CHAPEL HILL
• 依托单位国家: 美国
• 财政年份: 2002
• 资助国家: 美国
• 起止时间: 2002-07-01 至 2005-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6485152
• 关键词: acyltransferase; apoptosis; diabetic cardiomyopathy; enzyme activity; fibrosis; laboratory mouse; male; mitochondria; molecular pathology; noninsulin dependent diabetes mellitus; obesity; protein biosynthesis; triglycerides

DESCRIPTION (provided by applicant) In the United States, the rise in obesity and diabetes has led to a concomitant increase in the incidence of heart disease. An increased incidence of cardiovascular disease is the most common complication of non-insulin dependent diabetes (NIDDM) (1). In addition to atherosclerosis, NIDDM is associated with a specific cardiomyopathy resulting in ventricular dysfunction (1). Autopsies and animal studies have identified an increase in interstitial collagen and myocardial fibrosis which causes the physiological changes observed in the heart muscle (2). Recent studies indicate that excessive deposition of triacylglycerol (TAG) in the heart leads to apoptosis and fibrosis, providing a mechanism for the loss of cardiac function (3, 4). Glycerol-3-phosphate acyltransferase (GPAT) is, perhaps, the most important site in regulating triacylglycerol synthesis because it catalyzes the initial, committed, and rate limiting step (5). Our studies indicate, surprisingly, that compared to other organs that synthesize triacylglycerol (liver and adipose), the expression of mitochondrial GPAT protein is highest in the heart although activity is very low, suggesting that GPAT may be allosterically regulated. Our experiments also show that rat heart mitochondrial GPAT activity is up-regulated following a 48 h fast. These results, together with the findings in a recent study showing up-regulation of GPAT mRNA in the hearts of diabetic obese fa/fa rats (4), suggest that heart GPAT dysregulation under conditions of high fatty acid influx, such as diabetes, obesity, and fasting, may play an important role in the accumulation of triacylglycerol. The overall aim of this proposal is to elucidate the regulation of mitochondrial GPAT and its role in myocardial triacylglycerol accumulation, apoptosis and fibrosis.

描述(由申请人提供) 在美国，肥胖和糖尿病的增加导致了随之而来的 心脏病发病率的增加。增加的发病率 心血管疾病是非胰岛素依赖者最常见的并发症 糖尿病(NIDDM)(1)。除了动脉粥样硬化，NIDDM还与 一种导致心功能不全的特殊心肌病(1)。验尸报告 动物研究发现间质胶原蛋白增加， 心肌纤维化引起的生理变化观察到的 心肌(2)。最近的研究表明，过量的沉积 心脏中的三酰甘油(TAG)会导致细胞凋亡和纤维化，提供一种 心功能丧失的机制(3，4)。甘油-3-磷酸 酰基转移酶(GPAT)可能是调节 三酰甘油的合成，因为它催化初始、承诺和速率 限制步骤(5)。令人惊讶的是，我们的研究表明，与其他 合成三酰甘油的器官(肝脏和脂肪)，表达 线粒体GPAT蛋白在心脏中含量最高，尽管活性非常高 低，提示GPAT可能受变构调节。我们的实验也 显示大鼠心肌线粒体GPAT活性在48h后上调 快点。这些结果，加上最近一项研究的发现，表明 糖尿病肥胖大鼠心脏GPAT基因表达上调(4)， 提示高脂肪酸条件下心脏GPAT功能紊乱 大量涌入，如糖尿病、肥胖和禁食，可能在 三酰甘油的积累。这项建议的总体目标是 阐明线粒体GPAT的调控及其在心肌细胞中的作用 三酰甘油蓄积、细胞凋亡和纤维化。